These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19196031)

  • 1. Palmitoylation of the EGF receptor impairs signal transduction and abolishes high-affinity ligand binding.
    Macdonald-Obermann JL; Pike LJ
    Biochemistry; 2009 Mar; 48(11):2505-13. PubMed ID: 19196031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding.
    Adak S; Yang KS; Macdonald-Obermann J; Pike LJ
    J Biol Chem; 2011 Dec; 286(52):45146-55. PubMed ID: 22069315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular domain mutations of the EGF receptor differentially modulate high-affinity and low-affinity responses to EGF receptor ligands.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2024 Mar; 300(3):105763. PubMed ID: 38367671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization.
    Prywes R; Livneh E; Ullrich A; Schlessinger J
    EMBO J; 1986 Sep; 5(9):2179-90. PubMed ID: 3490969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis reveals a role for epidermal growth factor receptor extracellular subdomain IV in ligand binding.
    Saxon ML; Lee DC
    J Biol Chem; 1999 Oct; 274(40):28356-62. PubMed ID: 10497195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.
    Moriai T; Kobrin MS; Hope C; Speck L; Korc M
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10217-21. PubMed ID: 7937865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.
    Li Y; Macdonald-Obermann J; Westfall C; Piwnica-Worms D; Pike LJ
    J Biol Chem; 2012 Sep; 287(37):31116-25. PubMed ID: 22822073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.
    Li X; Huang Y; Jiang J; Frank SJ
    Cell Signal; 2008 Nov; 20(11):2145-55. PubMed ID: 18762250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites.
    Decker SJ
    J Biol Chem; 1993 May; 268(13):9176-9. PubMed ID: 8387484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of replacing EGFR juxtamembrane domain with an unstructured sequence.
    He L; Hristova K
    Sci Rep; 2012; 2():854. PubMed ID: 23152945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2014 Sep; 289(38):26178-26188. PubMed ID: 25086039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3.
    Walker F; Hibbs ML; Zhang HH; Gonez LJ; Burgess AW
    Growth Factors; 1998; 16(1):53-67. PubMed ID: 9777370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain.
    Hurwitz DR; Emanuel SL; Nathan MH; Sarver N; Ullrich A; Felder S; Lax I; Schlessinger J
    J Biol Chem; 1991 Nov; 266(32):22035-43. PubMed ID: 1657987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intracellular juxtamembrane domain of the epidermal growth factor (EGF) receptor is responsible for the allosteric regulation of EGF binding.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2009 May; 284(20):13570-13576. PubMed ID: 19336395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmitoylation of the sphingosine 1-phosphate receptor S1P is involved in its signaling functions and internalization.
    Ohno Y; Ito A; Ogata R; Hiraga Y; Igarashi Y; Kihara A
    Genes Cells; 2009 Aug; 14(8):911-23. PubMed ID: 19619245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF.
    Aviezer D; Yayon A
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12173-7. PubMed ID: 7991602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of substitution of threonine 654 of the epidermal growth factor receptor on epidermal growth factor-mediated activation of phospholipase C.
    Decker SJ; Ellis C; Pawson T; Velu T
    J Biol Chem; 1990 Apr; 265(12):7009-15. PubMed ID: 2108964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of binding, endocytosis, and recycling of EGF receptor mutants.
    Felder S; LaVin J; Ullrich A; Schlessinger J
    J Cell Biol; 1992 Apr; 117(1):203-12. PubMed ID: 1556153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2018 Aug; 293(35):13401-13414. PubMed ID: 29997256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.